Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Paclitaxel in Treating Older Patients With Solid Tumors

ClinicalTrials.gov ID: NCT00003092

Public ClinicalTrials.gov record NCT00003092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 2, 2026, 3:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Pharmacology of Paclitaxel in Relation to Patient Age

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase III trial to study the effectiveness of paclitaxel in treating older patients who have solid tumors.

Study identification

NCT ID
NCT00003092
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1997 (Type not available)
Primary completion
Mar 2006 (Actual)
Completion
Jun 2006 (Actual)
Last update posted
Jul 14, 2016

1997 – 2006

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Rebecca and John Moores UCSD Cancer Center La Jolla California 92093-0658 —
UCSF Cancer Center and Cancer Research Institute San Francisco California 94143-0128 —
CCOP - Christiana Care Health Services Wilmington Delaware 19899 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5000 —
CCOP - Mount Sinai Medical Center Miami Beach Florida 33140 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Holden Comprehensive Cancer Center Iowa City Iowa 52242-1009 —
Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland 21201 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
University of Massachusetts Memorial Medical Center - University Campus Worcester Massachusetts 01655 —
University of Minnesota Cancer Center Minneapolis Minnesota 55455 —
Ellis Fischel Cancer Center - Columbia Columbia Missouri 65203 —
Barnes-Jewish Hospital St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68198-7680 —
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
Norris Cotton Cancer Center Lebanon New Hampshire 03756-0002 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
CCOP - North Shore University Hospital Manhasset New York 11030 —
North Shore University Hospital Manhasset New York 11030 —
Memorial Sloan-Kettering Cancer Center New York New York 10021 —
New York Presbyterian Hospital - Cornell Campus New York New York 10021 —
Mount Sinai Medical Center, NY New York New York 10029 —
State University of New York - Upstate Medical University Syracuse New York 13210 —
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. Syracuse New York 13217 —
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina 27104-4241 —
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1082 —
Rhode Island Hospital Providence Rhode Island 02903 —
University of Tennessee Cancer Institute Memphis Tennessee 38103 —
Vermont Cancer Center Burlington Vermont 05401-3498 —
MBCCOP - Massey Cancer Center Richmond Virginia 23298-0037 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 14, 2016 · Synced Oct 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00003092 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →